Angiomax bivalirudin: Pilot data; marketed in New Zealand; under FDA and EMEA review

Baylor College of Medicine researchers presented data from 60 patients undergoing coronary

Read the full 124 word article

How to gain access

Continue reading with a
two-week free trial.